Clinical trial
An Open-label Assessment of Intravitreous Injections of Vitrase (Hyaluronidase for Injection) for Inducing Posterior Vitreous Detachment in Subjects With Moderate to Severe Non-proliferative Diabetic Retinopathy
NCT00198471 is registered in ClinicalTrials.gov with Bausch & Lomb Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Assessment of Intravitreous Injections of Vitrase (Hyaluronidase for Injection) for Inducing Posterior Vitreous Detachment in Subjects With Moderate to Severe Non-proliferative Diabetic Retinopathy
- Lead sponsor
- Bausch & Lomb Incorporated
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- November 30, 2006
- Enrollment
- 10
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.